It is a pharma private limited company based in Hyderabad., Telangana, India, established in 1995.
1995 | Hyderabad., Telangana, India | ActiveKar Therapeutics & Estates Private Limited, a active private limited company, was established on 14 June 1995 in Hyderabad., Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233TG1995PTC020683. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹29.98 Cr.
Formerly known as Dr.Reddy's Estates Private Limited. It upholds a compliant status. Its leadership includes Satish Reddy Kallam (Director), Kallam Deepti Reddy (Director). Past directors included Anjireddy Kallam, Preksha Fulfagar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 7-1-27, Ameerpet,Hyderabad. Hyderabad., Hyderabad., Telangana.
U24233TG1995PTC020683
020683
14 June 1995
₹30.00 Cr
₹29.98 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Kar Therapeutics & Estates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satish Reddy Kallam | Director | 14 Jun 1995 | Current |
| Kallam Deepti Reddy | Director | 28 Jul 1995 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Mar 2013 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kar Therapeutics & Estates Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 83.8% increase. The company also saw a substantial improvement in profitability, with a 32.91% increase in profit. The company's net worth dipped by a decrease of 8.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Kar Therapeutics & Estates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kar Therapeutics & Estates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kar Therapeutics & Estates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kar Therapeutics & Estates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kar Therapeutics & Estates Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Vikash Rajak was appointed as a Company Secretary was appointed as a Company Secretary on 16 Sep 2025 & has been associated with this company since 2 months 19 days . was recorded as a recent event.
Kar Therapeutics & Estates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
Progress on Kallam Deepti Reddy was appointed as a Director was appointed as a Director on 28 Jul 1995 & has been associated with this company since 30 years 4 months . was documented.
Progress on Satish Reddy Kallam was appointed as a Director was appointed as a Director on 14 Jun 1995 & has been associated with this company since 30 years 5 months . was documented.
Kar Therapeutics & Estates Private Limited was registered on 14 Jun 1995 with Roc Hyderabad & aged 30 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Kar Therapeutics & Estates Private Limited is U24233TG1995PTC020683.
Kar Therapeutics & Estates Private Limited is headquartered at 7-1-27, Ameerpet,Hyderabad. Hyderabad., Hyderabad., Telangana.
Kar Therapeutics & Estates Private Limited was incorporated on 14 June 1995.
The current directors of Kar Therapeutics & Estates Private Limited are
The primary industry of Kar Therapeutics & Estates Private Limited is Manufacturing.
Kar Therapeutics & Estates Private Limited is unlisted.
The authorized capital of Kar Therapeutics & Estates Private Limited is ₹30.00 Cr, and the paid-up capital is ₹29.98 Cr.
The compliance status of Kar Therapeutics & Estates Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX